These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6287349)

  • 61. Hepatobiliary effects of morphine are mediated in the brain.
    Hurwitz A; Looney G; Sullins M; Ben-Zvi Z
    Hepatology; 1990 Dec; 12(6):1406-12. PubMed ID: 2175293
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prolactin and growth hormone release by morphine in the rat: different receptor mechanisms.
    Spiegel K; Kourides IA; Pasternak GW
    Science; 1982 Aug; 217(4561):745-7. PubMed ID: 6285470
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Naloxazone and pain-inhibitory systems: evidence for a collateral inhibition model.
    Kirchgessner AL; Bodnar RJ; Pasternak GW
    Pharmacol Biochem Behav; 1982 Dec; 17(6):1175-9. PubMed ID: 7163350
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Ontogeny of opioid pharmacology and receptors: high and low affinity site differences.
    Zhang AZ; Pasternak GW
    Eur J Pharmacol; 1981 Jul; 73(1):29-40. PubMed ID: 6274643
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Analgesia and the blood-brain barrier transport system for Tyr-MIF-1/enkephalins: evidence for a dissociation.
    Banks WA; Kastin AJ; Nager BJ
    Neuropharmacology; 1988 Feb; 27(2):175-9. PubMed ID: 2895431
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Failure to demonstrate mu-isoreceptors.
    Rourke JD; Shaw JS
    Neuropeptides; 1984 Dec; 5(1-3):85-8. PubMed ID: 6099520
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Opioid receptor upregulation and supersensitivity in mice: effect of morphine sensitivity.
    Yoburn BC; Kreuscher SP; Inturrisi CE; Sierra V
    Pharmacol Biochem Behav; 1989 Mar; 32(3):727-31. PubMed ID: 2544906
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Duration of opiate receptor blockade determines tumorigenic response in mice with neuroblastoma: a role for endogenous opioid systems in cancer.
    Zagon IS; McLaughlin PJ
    Life Sci; 1984 Jul; 35(4):409-16. PubMed ID: 6087062
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Genetic influences on brain stimulation-produced analgesia in mice: II. Correlation with brain opiate receptor concentration.
    Marek P; Yirmiya R; Liebeskind JC
    Brain Res; 1990 Jan; 507(1):155-7. PubMed ID: 2154297
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Inhibition of morphine-induced analgesia and locomotor activity in strains of mice: a comparison of long-acting opiate antagonists.
    Frischknecht HR; Siegfried B; Riggio G; Waser PG
    Pharmacol Biochem Behav; 1983 Dec; 19(6):939-44. PubMed ID: 6657726
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Naltrexone prevents footshock-induced performance deficit in rats.
    McCubbin JA; Kizer JS; Lipton MA
    Life Sci; 1984 May; 34(21):2057-66. PubMed ID: 6328153
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Naltrexone modulates growth in infant rats.
    Zagon IS; McLaughlin PJ
    Life Sci; 1983 Dec; 33(24):2449-54. PubMed ID: 6316064
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Opioid receptor antagonist affinity ligands: 6 beta-bromoacetamido-6-desoxynaltrexone and 6 beta-thioglycolamido-6-desoxynaltrexone.
    Manda S; Lerner-Marmarosh N; Hashmi M; Abood LG
    Neurochem Res; 1992 Dec; 17(12):1191-4. PubMed ID: 1334238
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Differential blockade by naloxonazine of two mu opiate actions: analgesia and inhibition of gastrointestinal transit.
    Paul D; Pasternak GW
    Eur J Pharmacol; 1988 May; 149(3):403-4. PubMed ID: 2842168
    [No Abstract]   [Full Text] [Related]  

  • 75. 3-Hydroxy-17-aralkylmorphinans as potential opiate receptor-site-directed alkylating agents.
    Portoghese PS; Hanson RN; Telang VG; Winger JL; Takemori AE
    J Med Chem; 1977 Aug; 20(8):1020-4. PubMed ID: 197237
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Correlation between pharmacological and opiate receptor binding activities of tetrapeptide acylhydrazide analogs of enkephalin.
    Kawai K; Ishii H; Doi T; Tamura S; Shinagawa S; Fujino M
    Eur J Pharmacol; 1981 Jul; 72(4):297-304. PubMed ID: 6268417
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Respiratory effects and tolerability of Mr 2264 Cl. A new opiate partial agonist in comparison with morphine and placebo.
    Behne M; Bremerich D; Heinrich J; Schumacher H; Scherer M
    Eur J Clin Pharmacol; 1994; 46(4):301-4. PubMed ID: 7957512
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Developmental differences between high and low affinity opiate binding sites: their relationship to analgesia and respiratory depression.
    Pasternak GW; Zhang A; Tecott L
    Life Sci; 1980 Sep; 27(13):1185-90. PubMed ID: 6252404
    [No Abstract]   [Full Text] [Related]  

  • 79. Serotonergic and opiate interactions in the modulation of drug- and environmental-induced analgesia in the neonatal rat pup.
    Enters EK; Spear LP
    Behav Neural Biol; 1988 Jul; 50(1):80-97. PubMed ID: 2840888
    [TBL] [Abstract][Full Text] [Related]  

  • 80. 3-[18F]Acetylcyclofoxy: a useful probe for the visualization of opiate receptors in living animals.
    Pert CB; Danks JA; Channing MA; Eckelman WC; Larson SM; Bennett JM; Burke TR; Rice KC
    FEBS Lett; 1984 Nov; 177(2):281-6. PubMed ID: 6094248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.